You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd.

BSE: 524663 Sector: Health care
NSE: N.A. ISIN Code: INE994B01014
BSE LIVE 14:56 | 08 Dec 21.35 0.30
(1.43%)
OPEN

21.50

HIGH

21.70

LOW

21.00

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 21.50
PREVIOUS CLOSE 21.05
VOLUME 29824
52-Week high 33.50
52-Week low 16.65
P/E 64.70
Mkt Cap.(Rs cr) 92.19
Buy Price 21.15
Buy Qty 41.00
Sell Price 21.35
Sell Qty 550.00
OPEN 21.50
CLOSE 21.05
VOLUME 29824
52-Week high 33.50
52-Week low 16.65
P/E 64.70
Mkt Cap.(Rs cr) 92.19
Buy Price 21.15
Buy Qty 41.00
Sell Price 21.35
Sell Qty 550.00

About Bharat Immunological & Biological Corporation Ltd.

Bharat Immunological & Biological Corporation Ltd

Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations. The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96. ...> More

Bharat Immunological & Biological Corporation Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   92
EPS - TTM () [*S] 0.33
P/E Ratio (X) [*S] 64.70
Face Value ()   10
Latest Dividend (%)   -
Latest Dividend Date -
Dividend Yield (%) 0.00
Book Value / Share () [*S] 8.40
P/B Ratio () [*S] 2.54
[*C] Consolidated     [*S] Standalone

Bharat Immunological & Biological Corporation Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 11.01 13.41 -17.9
Other Income 0.33 0.34 -2.94
Total Income 11.34 13.76 -17.59
Total Expenses 8.57 17.17 -50.09
Operating Profit 2.77 -3.42 180.99
Net Profit 1.55 -3.71 141.78
Equity Capital 43.18 43.18 -
> More on Bharat Immunological & Biological Corporation Ltd Financials Results

Bharat Immunological & Biological Corporation Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Venus Remedies 92.20 0.22 105.48
Nutraplus India 62.40 -0.24 96.72
Jagsonpal Pharma 35.45 0.00 92.88
Bharat Immunolog 21.35 1.43 92.19
Fervent Synerg. 30.25 -7.21 90.75
Gennex Lab. 6.59 -0.15 83.36
Aarey Drugs 44.95 3.21 79.02
> More on Bharat Immunological & Biological Corporation Ltd Peer Group

Bharat Immunological & Biological Corporation Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 59.25
Banks/FIs 0.00
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 31.35
Custodians 0.00
Other 9.39
> More on Bharat Immunological & Biological Corporation Ltd Share Holding Pattern

Bharat Immunological & Biological Corporation Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -0.93% NA 0.47% 0.65%
1 Month -2.29% NA -3.29% -3.48%
3 Month 25.96% NA -8.13% -7.89%
6 Month 9.77% NA -1.25% -0.32%
1 Year -26.63% NA 5.43% 7.07%
3 Year 103.53% NA 27.09% 31.73%

Bharat Immunological & Biological Corporation Ltd - STOCK STRENGTH

Today's Low/High 21.00
21.70
Week Low/High 20.60
23.00
Month Low/High 17.50
23.00
YEAR Low/High 16.65
34.00
All TIME Low/High 0.25
74.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard